Compounded GLP-1 receptor agonist (semaglutide)

Compounded Semaglutide for Women: Status and Cautions

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026

Quick answer

Compounded semaglutide is a pharmacy-mixed version of the drug in Wegovy and Ozempic. It is not FDA-approved, and its availability dropped sharply after the FDA declared the semaglutide shortage resolved in early 2025, which restricts large-scale compounding. Safety and potency are not FDA-verified, and the same pregnancy cautions apply.

How it works

The active ingredient is semaglutide, working like the branded GLP-1 drugs. However, compounded products are prepared by pharmacies rather than manufactured under FDA approval, so purity, dose accuracy, and salt forms are not FDA-reviewed.

FDA status for weight: Not FDA-approved. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. Compounding is now legally limited because the semaglutide shortage was declared resolved in early 2025.

Women-specific considerations

These are factual notes from FDA labels and published guidelines, not personal medical advice. Discuss your situation with a licensed clinician.

Unverified potency

Because dose accuracy is not FDA-verified, guidance that depends on a known dose, including pregnancy-timing planning, is harder to apply safely.

Pregnancy and breastfeeding

The same semaglutide cautions apply in principle: stop before a planned pregnancy and avoid while breastfeeding. Unverified products make these harder to follow.

PCOS

There is no FDA approval for compounded semaglutide in PCOS or any indication. Any use is both off-label and outside FDA review.

Counterfeit risk

The FDA has warned about unapproved and counterfeit semaglutide products sold outside the regulated supply chain, which can carry unknown ingredients.

Who it is for (eligibility)

There is no FDA eligibility standard for compounded semaglutide. Legitimate compounding is now limited to specific clinical situations under a licensed prescriber and pharmacy. FDA-approved options are Wegovy (weight) and Ozempic (diabetes).

Cost (cited)

Cash-pay (503A pharmacies, now largely ended)

Varied by pharmacy; access ended after FDA resolved the shortage

FDA — Compounding and the FDA: Questions and Answers ↗

Current availability

Pricing varies (restricted)

FDA — Compounding and the FDA: Questions and Answers ↗

See the full cost breakdown in our cost guide.

Related questions

Frequently asked questions

Is compounded semaglutide legal in 2026?
It is sharply limited. After the FDA declared the semaglutide shortage resolved in early 2025, large-scale compounding is restricted, and legitimate compounding is confined to specific clinical situations.
Is compounded semaglutide safe for women?
Compounded semaglutide is not FDA-verified for potency, purity, or safety, and the FDA has warned about counterfeit versions. Any use carries added uncertainty for pregnancy timing and general safety.
What are the FDA-approved alternatives?
Wegovy (semaglutide 2.4 mg) is FDA-approved for weight, and Ozempic is FDA-approved for type 2 diabetes. Both are manufactured under FDA approval, unlike compounded products.

Sources

Every claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.

For the general (non women-specific) mechanism, dosing, and side-effect incidence, see our semaglutide medication overview.

Compare other options

ClearHormones updates this explainer as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.